Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02275039
Title p53MVA Vaccine and Gemcitabine Hydrochloride in Treating Patients With Recurrent Ovarian Epithelial Cancer
Recruitment Completed
Gender female
Phase Phase I
Variant Requirements Yes
Sponsors City of Hope Medical Center
Indications

peritoneal carcinoma

ovary epithelial cancer

fallopian tube carcinoma

Therapies

MVAp53

Gemcitabine

Age Groups: adult
Covered Countries USA

Additional content available in CKB BOOST